Business Segments Oxford Nanopore Technologies plc
Equities
ONT
GB00BP6S8Z30
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.15 GBX | -2.69% |
|
+4.65% | -5.30% |
| 04-20 | Roadside Real Estate CEO buys after Hoch purchase | AN |
| 04-15 | Cepheid and Oxford Nanopore Technologies Expand Partnership for Infectious Disease Research Collaboration | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Life Science Research Tools (LSRT) | 65.53M | 127M | 147M | 170M | 183M | |||||
Total Assets | 130M | 189M | 245M | 279M | 742M | |||||
Interest Expense | -747K | -908K | -1.6M | -2.21M | -3.56M | |||||
Income Tax Expense | - | 1.61M | 7.61M | 4.74M | 6.23M | |||||
CAPEX | -26.79M | -34.31M | -57.78M | - | -13.94M | |||||
EBT | -87.85M | - | - | - | -140M | |||||
Gross Profit | - | - | 82.7M | 90.5M | 105M | |||||
EBITDA | -68.85M | -60.68M | -78.63M | -105M | - | |||||
D&A | 12.37M | 23.08M | 31.8M | 41.63M | 19.58M | |||||
Operating Income | - | - | - | - | -152M | |||||
Net Income | - | -169M | -129M | -155M | -146M | |||||
Total Assets | - | - | - | 1.03M | - | |||||
Total Assets | - | 131M | 204M | 258M | - | |||||
Total Assets | 1.44M | 6.08M | 7.68M | 5.49M | - | |||||
Total Assets | 20.7M | 14.27M | 9.15M | 12.82M | - | |||||
Total Assets | 62K | - | 2.06M | 261K | - | |||||
Total Assets | 80.86M | 488M | 357M | 221M | - | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
COVID Testing | 48.33M | 6.7M | 51.79M | - | - | |||||
Total Assets | 48.31M | 14.42M | - | - | - | |||||
Interest Expense | - | - | -25K | - | - | |||||
CAPEX | -6.36M | - | - | - | - | |||||
EBT | 14.7M | - | - | - | - | |||||
Gross Profit | - | - | 41.1M | - | - | |||||
EBITDA | 15.2M | 2.94M | - | - | - | |||||
D&A | 128K | 1.62M | 72K | - | - | |||||
Net Income | - | 1.33M | 37.8M | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Rest of World | 13.78M | - | - | - | 75.7M | |||||
Total Assets | - | - | - | - | 3.5M | |||||
USA | 16.41M | - | - | - | 56.16M | |||||
Total Assets | - | - | - | - | 15.73M | |||||
United Kingdom | 52.88M | - | - | - | 21.13M | |||||
Total Assets | - | - | - | - | 126M | |||||
China | 7.72M | 10.98M | 19.29M | - | 16.04M | |||||
Total Assets | - | 320K | 96K | - | - | |||||
Germany | - | - | - | - | 11.01M | |||||
United Arab Emirates | - | 31.72M | 15.38M | - | 3.15M | |||||
Total Assets | - | - | 122K | - | - | |||||
Europe, The Middle East, Africa, and India | - | - | - | 74.04M | - | |||||
Total Assets | - | - | - | 310M | - | |||||
APAC | - | - | - | 34.09M | - | |||||
Total Assets | - | - | - | 1.06M | - | |||||
Emerging Markets | - | 6.36M | 6.22M | - | - | |||||
Asia Pacific and Japan | - | 11.13M | 14.29M | - | - | |||||
Total Assets | - | 83K | 335K | - | - | |||||
Europe and United Kingdom | - | 40.1M | 95.12M | - | - | |||||
Total Assets | - | 78.75M | 166M | - | - | |||||
Americas | - | 33.37M | 48.3M | 61.54M | - | |||||
Total Assets | - | 6.02M | 11.26M | 13.13M | - | |||||
Europe Excluding UK | 18.91M | - | - | - | - | |||||
Japan | 4.16M | - | - | - | - |
- Stock Market
- Equities
- ONT Stock
- Financials Oxford Nanopore Technologies plc
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















